Dermata Therapeutics Inc
NASDAQ:DRMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dermata Therapeutics Inc
NASDAQ:DRMA
|
US |
|
SPAR Group Ltd
OTC:SGPPF
|
ZA |
|
D
|
Dai Nippon Printing Co Ltd
OTC:DNPCF
|
JP |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
Cybertech Systems and Software Ltd
NSE:CYBERTECH
|
IN |
|
Phunware Inc
NASDAQ:PHUN
|
US |
|
V
|
Valtecne SpA
MIL:VLT
|
IT |
|
P
|
Palfinger AG
VSE:PAL
|
AT |
|
AKR Corporindo Tbk PT
IDX:AKRA
|
ID |
|
Mitsubishi Gas Chemical Co Inc
F:MUG
|
JP |
|
TOMI Environmental Solutions Inc
NASDAQ:TOMZ
|
US |
Intrinsic Value
The intrinsic value for
Dermata Therapeutics Inc (DRMA) under the Base Case is hidden
USD.
Compared with the current market price of 1.26 USD, the stock appears hidden
.
DRMA looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether DRMA usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Dermata Therapeutics Inc.
The intrinsic value for
Dermata Therapeutics Inc (DRMA) under the Base Case is hidden USD.
Compared with the current market price of 1.26 USD, the stock appears hidden.